LUNG DIFFUSION CAPACITY AND NON-SPECIFIC INFLAMMATION MARKERS IN PATIENTS WITH CORONARY HEART DISEASE AND DIABETES MELLITUS
https://doi.org/10.15829/1560-4071-2013-6-33-38
Abstract
Aim. To assess the differences in the lung diffusion capacity and non-specific inflammation markers among patients with coronary heart disease (CHD) and the combination of CHD and Type 2 diabetes mellitus (DM-2).
Material and methods. The study included 70 CHD patients: with DM-2 (n=40; 57,1%) and without DM-2 (n=30; 42,9%). Lung diffusion capacity (DIco) was assessed with the single-breath method and subsequent correction by haemoglobin levels (DIco cor). The levels of the following non-specific inflammation markers were also assessed: IL-1
About the Authors
E. D. Bazdyrev
Research Institute for Complex Cardiovascular Disease Issues, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo, Russia
Russian Federation
Russian Federation
Yu. V. Bayrakova
Research Institute for Complex Cardiovascular Disease Issues, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo, Russia
Russian Federation
Russian Federation
O. M. Polikutina
Research Institute for Complex Cardiovascular Disease Issues, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo, Russia
Russian Federation
Russian Federation
N. A. Bezdenezhnykh
Research Institute for Complex Cardiovascular Disease Issues, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo, Russia
Russian Federation
Russian Federation
Yu S. Slepynina
Research Institute for Complex Cardiovascular Disease Issues, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo, Russia
Russian Federation
Russian Federation
O. L. Barbarash
Research Institute for Complex Cardiovascular Disease Issues, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo, Russia
Russian Federation
Russian Federation
References
1. Knjazeva LI, Okrachkova IV, Bondyreva AV et al. Dynamics of activity indicators of immune inflammation in patients with type 2 diabetes mellitus under the influence of therapy. Modern Problems of Science and Education: Electron. Sci. J. 2012; 5 http://www.science-education.ru/105–7002 (18 March 2013). Russian (Князева Л. И., Окрачкова И. В., Бондырева А. В. и др. Динамика показателей активности иммун-
2. ного воспаления у больных сахарным диабетом 2 типа под влиянием терапии. Соврем. проблемы науки и образования: электрон. науч. журн. 2012; 5 http://www.science-education.ru/105–7002 (18 марта 2013).
3. Demidova TJu. Atherosclerosis and type 2 diabetes mellitus: mechanisms and management. CardioSomatika 2011; 2 (2):22–30. Russian (Демидова Т. Ю. Атеросклероз и сахарный диабет типа 2: механизмы и управление. CardioСоматика 2011; 2 (2):22–30).
4. Pizzi C, Manzoli L, Mancini S et al. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. Eur. Heart J. 2008; 29:1110–7.
5. Bojadzhjan AS, Arakelova JeA, Ajvazjan VA et al. Interleukins and chemokines in acute ischemic stroke, burdened and not burdened by a diabetes mellitus. Cytokines and Inflammation 2008; 1:41–4. Russian (Бояджян А. С., Аракелова Э. А., Айвазян В. А. и др. Интерлейкины и хемокины при остром ишемическом инсульте, отягощенном и не отягощенном диабетом. Цитокины и воспаление 2008; 1:41–4).
6. Boulbou MS, Gourgoulianis KI, Petinaki EA et al. Pulmonary function and circulating adhesion molecules in patients with diabetes mellitus. Can. Respir. J. 2003; 10 (5):259–64.
7. Litonjua A. A., Lazarus R., Sparrow D. et al. Lung function in type 2 diabetes: the Normative Aging Study. Respir. Med. 2005; 99:1583–90.
8. Avdeev SN, Bajmakanova GE. COPD and cardiovascular disease: mechanisms of association. Pulmonology 2008; 1:5–13. Russian (Авдеев С. Н., Баймаканова Г. Е. ХОБЛ и сердечно-сосудистые заболевания: механизмы ассоциации. Пульмонология 2008; 1:5–13).
9. American Diabetes Association. Standards of medical care in diabetes — 2011. Diabetes Care 2011; 34 (1):11–5.
10. Cardiology: a Guide for Physicians ed. R. G. Oganov, N. G. Fomin. М.;2006. Russian (Кардиология: руководство для врачей ред. Р. Г. Оганов, Н. Г. Фомин. М.;2006).
11. Shojhet JaN, Korenovskij JuV, Motin AV et al. The role of matrix metalloproteinases in inflammatory lung diseases. Probl. Clin. Medicine 2008; 3:99–102. Russian (Шойхет Я. Н., Кореновский Ю. В., Мотин А. В. и др. Роль матриксных металло-протеиназ при воспалительных заболеваниях легких. Проблемы клин. медицины. 2008; 3:99–102).
12. Cedenova EA, Volov NA, Lebedeva AJu. Choice of diagnostic method for the assessment of the risk of cardiovascular morbidity and mortality in patients with Q-wave myocardial infarction. Russ J Cardiol. 2007; 4:83–91. Russian (Цеденова Е. А., Волов Н. А., Лебедева А. Ю. Выбор метода диагностики для оценки степени риска сердечно-сосудистых осложнений и летальности у больных Q-образующим инфарктом
13. миокарда. Российский кардиологический журнал 2007; 4:83–91).
14. Koroleva OS, Zatejshhikov DA. Biomarkers in cardiology: registration intravascular inflammation. Farmateka 2007; 8/9:30–6. Russian (Королева О. С., Затейщиков Д. А. Биомаркеры в кардиологии: регистрация внутрисосудистого воспаления. Фарматека 2007; 8/9:30–6).
15. Packard RRS, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin. Chem. 2008; 54 (1):24–38.
16. Kulikova AN. The role of inflammation in atherogenesis in diabetes. Cytokines and Inflammation 2007; 3:14–9. Russian (Куликова А. Н. Роль воспаления в атерогенезе при сахарном диабете. Цитокины и воспаление 2007; 3:14–9).
Review
For citations:
Bazdyrev E.D., Bayrakova Yu.V., Polikutina O.M., Bezdenezhnykh N.A., Slepynina Yu.S., Barbarash O.L. LUNG DIFFUSION CAPACITY AND NON-SPECIFIC INFLAMMATION MARKERS IN PATIENTS WITH CORONARY HEART DISEASE AND DIABETES MELLITUS. Russian Journal of Cardiology. 2013;(6):33-38. (In Russ.) https://doi.org/10.15829/1560-4071-2013-6-33-38
Views:
649
Email this article 